{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:52:09Z","timestamp":1760298729354},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.leukres.2013.03.021","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T18:49:25Z","timestamp":1369162165000},"page":"1178-1183","source":"Crossref","is-referenced-by-count":30,"title":["Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Carla","family":"Casulo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Arcila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga L.","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Teruya-Feldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Maragulia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig H.","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.leukres.2013.03.021_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(19850715)56:2<333::AID-CNCR2820560222>3.0.CO;2-0","article-title":"Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease","volume":"56","author":"Ree","year":"1985","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2013.03.021_bib0010","first-page":"379","article-title":"Analysis of the Rye classification of Hodgkin's disease. The prognostic significance of cellular composition","volume":"51","author":"Coppleson","year":"1973","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.leukres.2013.03.021_bib0015","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/sj.onc.1205418","article-title":"Gene expression profiling defines molecular subtypes of classical Hodgkin's disease","volume":"21","author":"Devilard","year":"2002","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.leukres.2013.03.021_bib0020","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","article-title":"Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome","volume":"113","author":"Chetaille","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2013.03.021_bib0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2005-12-5125","article-title":"Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma","volume":"108","author":"Sanchez-Aguilera","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2013.03.021_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.leukres.2013.03.021_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/10428194.2012.698274","article-title":"Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma","volume":"54","author":"Deau","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"10.1016\/j.leukres.2013.03.021_bib0040","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1182\/blood-2010-09-288373","article-title":"How I treat relapsed and refractory Hodgkin lymphoma","volume":"117","author":"Kuruvilla","year":"2011","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.leukres.2013.03.021_bib0045","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM200205023461821","article-title":"Long-term follow-up of Hodgkin's disease trial","volume":"346","author":"Canellos","year":"2002","journal-title":"N Engl J Med"},{"issue":"8852","key":"10.1016\/j.leukres.2013.03.021_bib0050","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"issue":"9323","key":"10.1016\/j.leukres.2013.03.021_bib0055","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial","volume":"359","author":"Schmitz","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.leukres.2013.03.021_bib0060","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V97.3.616","article-title":"A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model","volume":"97","author":"Moskowitz","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2013.03.021_bib0065","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1182\/blood-2011-10-388058","article-title":"Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma","volume":"119","author":"Moskowitz","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2013.03.021_bib0070","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood.V96.4.1280","article-title":"Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group","volume":"96","author":"Josting","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2013.03.021_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1200\/JCO.20.1.221","article-title":"New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group","volume":"20","author":"Josting","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.leukres.2013.03.021_bib0080","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.leukres.2013.03.021_bib0085","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2013.03.021_bib0090","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1158\/1078-0432.CCR-12-2693","article-title":"Serum CD163 and TARC as disease response biomarkers in classical hodgkin lymphoma","volume":"19","author":"Jones","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"14","key":"10.1016\/j.leukres.2013.03.021_bib0095","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1158\/1078-0432.CCR-12-0129","article-title":"Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein\u2013Barr virus, lymphocyte subsets, and prognostic impact","volume":"18","author":"Barros","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.leukres.2013.03.021_bib0100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1634\/theoncologist.2012-0034","article-title":"The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages","volume":"17","author":"Koh","year":"2012","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.leukres.2013.03.021_bib0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0609.2011.01731.x","article-title":"CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma","volume":"88","author":"Yoon","year":"2012","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.leukres.2013.03.021_bib0110","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3109\/10428194.2011.580026","article-title":"The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma","volume":"52","author":"Jakovic","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.leukres.2013.03.021_bib0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00428-011-1140-8","article-title":"Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma","volume":"459","author":"Zaki","year":"2011","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.leukres.2013.03.021_bib0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3324\/haematol.2010.031542","article-title":"Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein\u2013Barr virus status in classical Hodgkin's lymphoma","volume":"96","author":"Kamper","year":"2011","journal-title":"Haematologica"},{"issue":"November","key":"10.1016\/j.leukres.2013.03.021_bib0125","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1182\/blood.V116.21.750.750","article-title":"An immunohistochemical score based on CD68 and FOXP3 expression in the tumour microenvironment at diagnosis defines prognostic groups in both early and advanced stage classical Hodgkin lymphoma","volume":"116","author":"Greaves","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.03.021_bib0130","first-page":"3881","article-title":"Marophages and mast cells infiltration are biomarkers of primary refractory Hodgkin's lymphoma","volume":"116","author":"Deau","year":"2010","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"1","key":"10.1016\/j.leukres.2013.03.021_bib0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2002-12-3842","article-title":"Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation","volume":"102","author":"Spaepen","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2013.03.021_bib0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1705416","article-title":"Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation","volume":"38","author":"Svoboda","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.leukres.2013.03.021_bib0145","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood-2005-11-006957","article-title":"Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma","volume":"109","author":"Schot","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2013.03.021_bib0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bmt.1703607","article-title":"Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma","volume":"30","author":"Cremerius","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.leukres.2013.03.021_bib0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2010.08162.x","article-title":"Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy","volume":"150","author":"Dickinson","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.leukres.2013.03.021_bib0160","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.leu.2402342","article-title":"Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation","volume":"16","author":"Becherer","year":"2002","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.leukres.2013.03.021_bib0165","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1182\/blood-2010-05-282756","article-title":"Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma","volume":"116","author":"Moskowitz","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2013.03.021_bib0170","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1182\/blood-2011-10-388058","article-title":"Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma","volume":"119","author":"Moskowitz","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2013.03.021_bib0175","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2011.04.011","article-title":"Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation","volume":"17","author":"Smeltzer","year":"2011","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613001082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613001082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T23:14:17Z","timestamp":1715382857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613001082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0145212613001082"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.03.021","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}